Femasys (FEMY) Interest & Investment Income (2020 - 2025)
Femasys (FEMY) reported Interest & Investment Income of $17144.0 for Q2 2025, down 90.69% on a YoY basis from $184138.0 in Q2 2024, and down 9.91% quarter-over-quarter from $19029.0 in Q1 2025.
Femasys (FEMY) Interest & Investment Income (2020 - 2025) Analysis & Trends
Femasys has reported Interest & Investment Income for 6 years, with the latest figure at $17144.0 in Q2 2025.
- For the quarter ending Q2 2025, Interest & Investment Income fell 90.69% year-over-year to $17144.0; the trailing twelve-month figure through Jun 2025 stood at $209705.0 (down 70.05% YoY), and the FY2025 full-year result was $101760.0, down 82.53% from the prior year.
- Interest & Investment Income for Q2 2025 stood at $17144.0, down from $19029.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $224684.0 in Q1 2024, with the low at $144.0 in Q2 2021.
- Historically, Interest & Investment Income has averaged $71193.2 across 5 years, with a median of $46078.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 18472.92% — and 2025, when it tumbled 91.53%.
- Femasys' Interest & Investment Income stood at $1811.0 in 2021, then surged by 6448.43% to $118592.0 in 2022, then jumped by 67.71% to $198886.0 in 2023, then slumped by 75.11% to $49504.0 in 2024, then tumbled by 65.37% to $17144.0 in 2025.
- The last three Interest & Investment Income figures came in at $17144.0 (Q2 2025), $19029.0 (Q1 2025), and $49504.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 17,144.00 |
| Mar 31, 2025 | 19,029.00 |
| Dec 31, 2024 | 49,504.00 |
| Sep 30, 2024 | 124,028.00 |
| Jun 30, 2024 | 184,138.00 |
| Mar 31, 2024 | 224,684.00 |
| Dec 31, 2023 | 198,886.00 |
| Sep 30, 2023 | 92,392.00 |
| Jun 30, 2023 | 42,652.00 |
| Mar 31, 2023 | 97,089.00 |
| Dec 31, 2022 | 118,592.00 |
| Sep 30, 2022 | 80,373.00 |
| Jun 30, 2022 | 26,745.00 |
| Mar 31, 2022 | 2,454.00 |
| Dec 31, 2021 | 1,811.00 |
| Sep 30, 2021 | 1,649.00 |
| Jun 30, 2021 | 144.00 |
| Mar 31, 2021 | 164.00 |
| Dec 31, 2020 | 206.00 |
| Sep 30, 2020 | 342.00 |